Literature DB >> 12425462

How do fatty acids cause allosteric binding of drugs to human serum albumin?

Victor Tuan Giam Chuang1, Masaki Otagiri.   

Abstract

PURPOSE: This study was undertaken to investigate how fatty acids cause the allosteric binding of drugs to human serum albumin (HSA). The influence of fatty acids on the binding of ketoprofen (KP), an NSAID, to HSA was examined by using a photoaffinity labeling technique.
METHODS: Ultrafiltration was performed to quantitate the concentration of free KP. HSA, photolabeled with KP in the presence of myristate (MYR), octanoate, and diazepam, was cleaved with cyanogen bromide, separated by Tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis and subsequently analyzed by autoradiography.
RESULTS: The addition of MYR at molar ratios from 4 to 5, but not from 1 to 2, causes substantial increases in unbound KP for KP:HSA ratios of 0.5 and 1. The addition of two or more moles of MYR, octanoate, and diazepam per mole of HSA caused a pronounced decrease in the labeling of the 11.6- and 13.5-kDa peptides. However, only MYR showed an increase in labeling of the 20 kDa and, especially, the 9.4-kDa peptides. At MYR:HSA ratios in excess of 3, a decrease in the extent of labeling of the 9.4-kDa peptide was observed.
CONCLUSION: Long-chain fatty acids regulate the binding properties of HSA in a complex manner, in which a simultaneous competitive and allosteric mechanism operates and which mainly involves domain I.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425462     DOI: 10.1023/a:1020496314081

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties.

Authors:  M Dockal; D C Carter; F Rüker
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

2.  Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.

Authors:  H Vorum; B Honoré
Journal:  J Pharm Pharmacol       Date:  1996-08       Impact factor: 3.765

3.  Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin.

Authors:  M H Rahman; K Yamasaki; Y H Shin; C C Lin; M Otagiri
Journal:  Biol Pharm Bull       Date:  1993-11       Impact factor: 2.233

4.  Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies.

Authors:  N Rietbrock; G Menke; G Reuter; A Lassmann; R Schmeidl
Journal:  J Clin Chem Clin Biochem       Date:  1985-11

Review 5.  Fatty acid binding to plasma albumin.

Authors:  A A Spector
Journal:  J Lipid Res       Date:  1975-05       Impact factor: 5.922

6.  Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin.

Authors:  J A Hamilton; S Era; S P Bhamidipati; R G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Inhaled anesthetic binding sites in human serum albumin.

Authors:  R G Eckenhoff; C E Petersen; C E Ha; N V Bhagavan
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I.

Authors:  I Petitpas; A A Bhattacharya; S Twine; M East; S Curry
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

9.  Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

Review 10.  Structure and ligand binding properties of human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Dan Med Bull       Date:  1990-02
View more
  12 in total

1.  Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.

Authors:  Paolo Ascenzi; Alessandro Bolli; Alessandra di Masi; Grazia R Tundo; Gabriella Fanali; Massimo Coletta; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2010-09-25       Impact factor: 3.358

Review 2.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

3.  Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Authors:  Mateusz P Czub; Katarzyna B Handing; Barat S Venkataramany; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

4.  Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method.

Authors:  Shin-ichi Fujiwara; Takashi Amisaki
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

5.  Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.

Authors:  Paolo Ascenzi; Alessandra di Masi; Massimo Coletta; Chiara Ciaccio; Gabriella Fanali; Francesco P Nicoletti; Giulietta Smulevich; Mauro Fasano
Journal:  J Biol Chem       Date:  2009-09-03       Impact factor: 5.157

6.  Effect of long-chain Fatty acids on the binding of triflupromazine to human serum albumin: a spectrophotometric study.

Authors:  Keisuke Kitamura; Shigehiko Takegami; Rumi Tanaka; Ahmed Ahmed Omran; Tatsuya Kitade
Journal:  Sci Pharm       Date:  2013-12-28

Review 7.  Heme-based catalytic properties of human serum albumin.

Authors:  P Ascenzi; A di Masi; G Fanali; M Fasano
Journal:  Cell Death Discov       Date:  2015-09-07

8.  Study on AgInZnS-Graphene Oxide Non-toxic Quantum Dots for Biomedical Sensing.

Authors:  Chi Song; Haoyue Luo; Xiaogang Lin; Zhijia Peng; Lingdong Weng; Xiaosheng Tang; Shibin Xu; Ming Song; Lifeng Jin; Xiaodong Zheng
Journal:  Front Chem       Date:  2020-05-05       Impact factor: 5.221

9.  Albumin in patients with liver disease shows an altered conformation.

Authors:  Margret Paar; Vera H Fengler; Daniel J Rosenberg; Angelika Krebs; Rudolf E Stauber; Karl Oettl; Michal Hammel
Journal:  Commun Biol       Date:  2021-06-14

10.  Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin.

Authors:  Alessio Bocedi; Giampiero De Sanctis; Chiara Ciaccio; Grazia R Tundo; Alessandra Di Masi; Gabriella Fanali; Francesco P Nicoletti; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.